Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532174) titled 'Efferon LPS Hemoadsorption in Cardiac Surgery Patients' on April 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Efferon JSC

Condition: Cardiac Disease Multiple Organ Dysfunction Syndrome

Intervention: Device: Efferon LPS

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: April 15, 2026

Target Sample Size: 60

Countries of Recruitment: Russia

To know more, visit https://clinicaltrials.gov/study/NCT07532174

Disclaimer: Curated by HT Syndication....